These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 34109886)

  • 1. Variability of three activated clotting time point-of-care systems in cardiac surgery: reinforcing available evidence.
    Solís Clavijo D; Cotano AO; Peña NA; Caballero Gálvez S; Arellano Núñez F; Carballo Caro JM; Muñoz-Cacho P; Tocón Alé C
    Perfusion; 2022 Oct; 37(7):711-714. PubMed ID: 34109886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Point-of-care measurement of activated clotting time for cardiac surgery as measured by the Hemochron signature elite and the Abbott i-STAT: agreement, concordance, and clinical reliability.
    Dirkmann D; Nagy E; Britten MW; Peters J
    BMC Anesthesiol; 2019 Sep; 19(1):174. PubMed ID: 31492108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transition from Hemochron Response to Hemochron Signature Elite Activated Clotting Time Devices in a Congenital Cardiac Surgery Practice.
    Matte GS; Howe RJ; Ibla J; Emani S; Emani SM
    J Extra Corpor Technol; 2019 Dec; 51(4):221-226. PubMed ID: 31915405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical monitoring of activated clotting time during cardiothoracic surgery: comparing the Hemochron
    Hoffmann RF; Horsten S; Mariani MA; de Vries AJ
    Perfusion; 2023 Mar; 38(2):285-291. PubMed ID: 34596463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interchangeability of activated clotting time values across different point-of-care systems.
    Thenappan T; Swamy R; Shah A; Nathan S; Nichols J; Bond L; Jolly N
    Am J Cardiol; 2012 May; 109(9):1379-82. PubMed ID: 22341924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative analysis of four activated clotting time measurement devices in cardiac surgery with cardiopulmonary bypass.
    Li H; Serrick C; Rao V; Yip PM
    Perfusion; 2021 Sep; 36(6):610-619. PubMed ID: 32885714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of a new point-of-care celite-activated clotting time analyzer in different clinical settings. The i-STAT celite-activated clotting time test.
    Paniccia R; Fedi S; Carbonetto F; Noferi D; Conti P; Bandinelli B; Giusti B; Evangelisti L; Pretelli P; Palmarini MF; Abbate R; Prisco D
    Anesthesiology; 2003 Jul; 99(1):54-9. PubMed ID: 12826842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraoperative Monitoring of Heparin: Comparison of Activated Coagulation Time and Whole Blood Heparin Measurements by Different Point-of-Care Devices with Heparin Concentration by Laboratory-Performed Plasma Anti-Xa Assay.
    Thompson TZ; Kunak RL; Savage NM; Agarwal S; Chazelle J; Singh G
    Lab Med; 2019 Oct; 50(4):348-356. PubMed ID: 31053856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of activated clotting times obtained using Hemochron and Medtronic analysers in patients receiving anti-thrombin therapy during cardiac catheterisation.
    Chia S; Van Cott EM; Raffel OC; Jang IK
    Thromb Haemost; 2009 Mar; 101(3):535-40. PubMed ID: 19277416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Hemochron Response RxDx heparin and protamine dosing system.
    Jaryno SA; Zucker ML; LaDuca FM
    J Extra Corpor Technol; 2004 Sep; 36(3):258-62. PubMed ID: 15559745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activated clotting time systems vary in precision and bias and are not interchangeable when following heparin management protocols during cardiopulmonary bypass.
    Welsby IJ; McDonnell E; El-Moalem H; Stafford-Smith M; Toffaletti JG
    J Clin Monit Comput; 2002 Jul; 17(5):287-92. PubMed ID: 12546261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of point-of-care activated clotting time systems utilized in a single pediatric institution.
    Ojito JW; Hannan RL; Burgos MM; Lim H; Huynh M; Velis E; Arocha M; Tirotta CF; Burke RP
    J Extra Corpor Technol; 2012 Mar; 44(1):15-20. PubMed ID: 22730859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hand-held personal digital assistant program for the HEMOCHRON RxDx heparin and protamine dosing system.
    El Rouby S; Rinehart K; Zucker ML; LaDuca FM
    J Extra Corpor Technol; 2003 Sep; 35(3):212-7. PubMed ID: 14653423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring activated clotting time for combined heparin and aprotinin application: in vivo evaluation of a new aprotinin-insensitive test using Sonoclot.
    Ganter MT; Monn A; Tavakoli R; Genoni M; Klaghofer R; Furrer L; Honegger H; Hofer CK
    Eur J Cardiothorac Surg; 2006 Aug; 30(2):278-84. PubMed ID: 16828293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of ACT point-of-care measurements: repeatability and agreement.
    Bosch YP; Ganushchak YM; de Jong DS
    Perfusion; 2006 Jan; 21(1):27-31. PubMed ID: 16485696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activated clotting time in inpatient diagnostic and interventional settings.
    Dalton H; Martin M; Garcia-Filion P; Shavelle D; Huang PH; Clark J; Beinart S; Israel A; Korpi-Steiner N
    J Thromb Thrombolysis; 2022 Nov; 54(4):660-668. PubMed ID: 35731496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New technology, old standards: disparate activated clotting time measurements by the Hemochron Jr compared with the standard Hemochron.
    Aylsworth CL; Stefan F; Woitas K; Rieger RH; LeBoutillier M; DiSesa VJ
    Ann Thorac Surg; 2004 Mar; 77(3):973-6. PubMed ID: 14992909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bedside coagulometry during intravenous heparin therapy after coronary angioplasty.
    Schroeder AP; Knudsen LL; Husted SE; Knudsen L; Ingerslev J
    J Thromb Thrombolysis; 2001 Oct; 12(2):157-63. PubMed ID: 11729367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Point-of-Care Measurement of Kaolin Activated Clotting Time during Cardiopulmonary Bypass: A Single Sample Comparison between ACT Plus and i-STAT.
    Vranken NPA; Theelen AJAJ; Orbons T; Barenbrug PJC; Weerwind PW
    J Extra Corpor Technol; 2021 Mar; 53(1):57-61. PubMed ID: 33814607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Individualized heparin and protamine management improves rotational thromboelastometric parameters and postoperative hemostasis in valve surgery.
    Vonk AB; Veerhoek D; van den Brom CE; van Barneveld LJ; Boer C
    J Cardiothorac Vasc Anesth; 2014 Apr; 28(2):235-41. PubMed ID: 24342152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.